SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
polycystic kidney disease
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
19
1
Presence of De Novo Mutations in Autosomal Dominant Polycystic Kidney Disease Patients Without Family History
2
Author Correction: Hydrophobic pore gates regulate ion permeation in polycystic kidney disease 2 and 2L1 channels (Nature Communications, (2018), 9, 1, (2302), 10.1038/s41467-018-04586-x)
3
A novel splicing mutation in the PKD1 gene causes autosomal dominant polycystic kidney disease in a Chinese family: a case report.
4
The pathobiology of polycystic kidney disease from a metabolic viewpoint
5
Comparison of the Hepatotoxic Potential of Two Treatments for Autosomal-Dominant Polycystic Kidney DiseaseUsing Quantitative Systems Toxicology Modeling.
6
Collagen-driven remodeling of the intrahepatic duct wall in the PCK rat model of polycystic kidney disease-Caroli syndrome.
7
pathways, perspectives and pursuits in polycystic kidney disease
8
anesthetic considerations in a patient of autosomal dominant polycystic kidney disease on hemodialysis for emergency cesarean section
9
autopsy report with clinical and pathophysiologic discussion of autosomal dominant adult polycystic kidney disease
10
emerging therapies for childhood polycystic kidney disease
11
an unusual cardiac manifestation in autosomal dominant polycystic kidney disease
12
emphysematous pyelonephritis in a patient with polycystic kidney disease
13
medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the usa: a retrospective matched cohort analysis of private insurer data
14
prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the tempo 3:4 clinical trial
15
tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations
16
Polycystic kidney disease ryanodine receptor domain (Pkdrr) proteins in oomycetes
17
Vancomycin Concentrations in Autosomal Dominant Polycystic Kidney Disease
18
Fibulin Levels in Autosomal Dominant Polycystic Kidney Disease and Its Relationship to Arterial Stiffness.
19
Development and validation of the thirst distress scale for patients with autosomal dominant polycystic kidney disease.
×
SciMatic on Your Phone
Track your articles, view certificates, and stay updated — anywhere, anytime.
Google Play